BEAUTY HEALTH CO/THE (SKIN)
US88331L1089 - Common Stock
BEAUTY HEALTH CO/THE
NASDAQ:SKIN (11/21/2024, 8:00:02 PM)
After market: 1.3701 -0.02 (-1.43%)1.39
-0.1 (-6.71%)
Company Profile
The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company is headquartered in Long Beach, California and currently employs 881 full-time employees. The company went IPO on 2020-02-10. The firm and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The firm is personalizing skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system (Delivery System) that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in microneedling with its products that are designed to provide a minimally-invasive microneedling skin treatment to help stimulate collagen and elastin production. Keravive specializes in scalp health with its products that are designed to cleanse, exfoliate, and hydrate the scalp and hair follicles. Hydrafacial's primary product offerings are the Syndeo device and its associated serum solutions and consumables.
Company Info
BEAUTY HEALTH CO/THE
2165 Spring Street
Long Beach CALIFORNIA 33139
P: 18006034996
CEO: Brenton L. Saunders
Employees: 881
Website: https://investors.beautyhealth.com/
SKIN News
4 days ago - StockStoryPersonal Care Stocks Q3 Recap: Benchmarking e.l.f. (NYSE:ELF)Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including e.l.f. (NYSE:ELF) and its peers.
9 days ago - StockStoryBeautyHealth (SKIN) Stock Trades Up, Here Is WhyShares of skincare company BeautyHealth (NASDAQ:SKIN) jumped 18.2% in the morning session after the company reported impressive third-quarter earnings that blew past analysts' EBITDA and EBITDA guidance expectations. Notably, the company turned a profit while Wall Street had predicted a loss. Revenue also beat expectations, though sales declined relative to the previous year. The decline in revenue was primarily due to challenges in system sales, particularly in international markets like China. As a result, the company reduced its full-year sales outlook. To overcome some of the challenges impeding growth, the company revamped its commercial leadership team and appointed a new Chief Revenue Officer and Chief Marketing Officer with more relevant expertise. Also, it provided more flexible pricing for markets affected by high interest rates and limited financing availability.
10 days ago - ChartmillCurious about the stocks that are showing activity after the closing bell on Tuesday?Get insights into the top gainers and losers of Tuesday's after-hours session.
10 days ago - StockStoryBeautyHealth’s (NASDAQ:SKIN) Q3 Sales Beat Estimates, Stock Jumps 17.1%Skincare company BeautyHealth (NASDAQ:SKIN) announced better-than-expected revenue in Q3 CY2024, but sales fell 19.1% year on year to $78.8 million. On the other hand, the company’s full-year revenue guidance of $327 million at the midpoint came in 4.1% below analysts’ estimates. Its GAAP loss of $0.15 per share was 55.2% below analysts’ consensus estimates.
10 days ago - The Beauty Health CompanyBeautyHealth Reports Third Quarter 2024 Financial Results11 days ago - StockStoryBeautyHealth (SKIN) Reports Q3: Everything You Need To Know Ahead Of EarningsSkincare company BeautyHealth (NASDAQ:SKIN) will be reporting results tomorrow afternoon. Here’s what you need to know.
SKIN Twits
Here you can normally see the latest stock twits on SKIN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
